当前位置: 首页 > 期刊 > 《中国医学创新》 > 2019年第4期
编号:13392329
本院232例抗菌药物不良反应报告分析(4)
http://www.100md.com 2019年2月5日 《中国医学创新》 2019年第4期
     [13] Harpaz R,Dumochel W,Shah N H.Big Data and Adverse Drug Reaction Detection[J].Clinical Pharmacology & Therapeutics,2016,99(3):268-270.

    [14]梁冰,张建伟,张荣厚.2015年-2016年某医院316例药品不良反应报告分析[J].实用医药杂志,2017,34(90):811-814.

    [15] Dorji C,Tragulpiankit P,Riewpaiboon A,et al.Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan:A Cross-Sectional Survey[J].Drug Safety,2016,39(12):1239-1250.

    [16] Hawcutt D B,Russell N,Maqsood H,et al.Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010:content and utility analysis[J].British Journal of Clinical Pharmacology,2016,82(6):1601-1612.

    [17]彭评志,蒙光义,庞家莲,等.206例抗菌药物不良反应报告分析[J].中国药业,2015,24(8):82-84.

    [18] Chisaki Y,Aoji S,Yano Y.Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report(JADER)Database[J].Biological & Pharmaceutical Bulletin,2017,40(6):824-829.

    [19] MullerHansma A H G,DaemenGubbels C R G M,Schut N H.

    Cholesterol embolisms as possible adverse drug reaction of direct oral anticoagulants[J].Netherlands Journal of Medicine,2018,76(3):125-128.

    [20]范芳芳,趙生俊,聂继红.我院2009年170例药品不良反应报告分析[J].中国药房,2011,22(7):651-653.

    (收稿日期:2018-07-10) (本文编辑:周亚杰), 百拇医药(周文雅)
上一页1 2 3 4